Abstract
Inflammatory bowel disease (IBD) is a chronic disease with periods of exacerbation and remission of the disease. The etiology of IBD is not fully understood. Many studies point to the presence of genetic, immunological, environmental, and microbiological factors and the interactions between them in the occurrence of IBD. The review looks at genetic factors in the context of both IBD predisposition and pharmacogenetics.
Subject
Genetics (clinical),Genetics
Reference214 articles.
1. Dudley, M., Kojinkov, M., and Baraga, D. (2022, September 13). ECCO-EFCCA Patient Guidelines on Crohn’s Disease (CD), European Crohn’s and Colitis Organisation: 2016. Available online: https://efcca.org/projects/ecco-efcca-patient-guidelines,.
2. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management;Dignass;J. Crohn’s Colitis,2017
3. Evolving Epidemiology of IBD;Windsor;Curr. Gastroenterol. Rep.,2019
4. The four epidemiological stages in the global evolution of inflammatory bowel disease;Kaplan;Nat. Rev. Gastroenterol. Hepatol.,2021
5. The epidemiology of inflammatory bowel disease: East meets west;Mak;J. Gastroenterol. Hepatol.,2020
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献